AAAAAA

   
Results: 1-25 | 26-31
Results: 1-25/31
HCV-ASSOCIATED FIBROSING CHOLESTATIC HEPATITIS AFTER RENAL-TRANSPLANTATION - RESPONSE TO INTERFERON-ALPHA THERAPY
Authors: ROSENBERG PM TOTH CM PASCUAL M DIENSTAG JL COSIMI SB CHUNG RT
Citation: Pm. Rosenberg et al., HCV-ASSOCIATED FIBROSING CHOLESTATIC HEPATITIS AFTER RENAL-TRANSPLANTATION - RESPONSE TO INTERFERON-ALPHA THERAPY, Hepatology, 28(4), 1998, pp. 736-736
HEPATITIS-C VIRUS-ASSOCIATED FIBROSING CHOLESTATIC HEPATITIS AFTER RENAL-TRANSPLANTATION - RESPONSE TO INTERFERON-ALPHA THERAPY
Authors: TOTH CM PASCUAL M CHUNG RT GRAEMECOOK F DIENSTAG JL BHAN AK COSIMI AB
Citation: Cm. Toth et al., HEPATITIS-C VIRUS-ASSOCIATED FIBROSING CHOLESTATIC HEPATITIS AFTER RENAL-TRANSPLANTATION - RESPONSE TO INTERFERON-ALPHA THERAPY, Transplantation, 66(9), 1998, pp. 1254-1258
CLINICAL AND EPIDEMIOLOGIC PREDICTORS OF RECURRENT CYTOMEGALOVIRUS DISEASE IN ORTHOTOPIC LIVER-TRANSPLANT RECIPIENTS
Authors: FALAGAS ME SNYDMAN DR GRIFFITH J WERNER BG FREEMAN R ROHRER R FAIRCHILD R FAWAZ K HOFFMAN MA KAPLAN M GILL M RUBIN RH DIENSTAG JL DORAN M OROURKE E VACANTI J JENKINS R LEWIS WD HAMMER S MARTIN M GRADY GF LESZCZYNSKI J DOUGHERTY N KATZ A FAUSETT G PLATT R CHEESEMAN SH PASTERNACK M GORBACH SL
Citation: Me. Falagas et al., CLINICAL AND EPIDEMIOLOGIC PREDICTORS OF RECURRENT CYTOMEGALOVIRUS DISEASE IN ORTHOTOPIC LIVER-TRANSPLANT RECIPIENTS, Clinical infectious diseases, 25(2), 1997, pp. 314-317
SURVEILLANCE CULTURES OF BLOOD, URINE, AND THROAT SPECIMENS ARE NOT VALUABLE FOR PREDICTING CYTOMEGALOVIRUS DISEASE IN LIVER-TRANSPLANT RECIPIENTS
Authors: FALAGAS ME SNYDMAN DR RUTHAZER R WERNER BG GRIFFITH J ROHRER R FREEMAN R FAWAZ K HOFFMAN MA KAPLAN M GILL M RUBIN RH DIENSTAG JL DORAN M OROURKE E VACANTI J JENKINS R LEWIS WD HAMMER S MARTIN M FAIRCHILD R WERNER BG GRADY GF LESZCZYNSKI J DOUGHERTY N KATZ A FAUSETT G PLATT R CHEESEMAN SH PASTERNACK M GORBACH SL
Citation: Me. Falagas et al., SURVEILLANCE CULTURES OF BLOOD, URINE, AND THROAT SPECIMENS ARE NOT VALUABLE FOR PREDICTING CYTOMEGALOVIRUS DISEASE IN LIVER-TRANSPLANT RECIPIENTS, Clinical infectious diseases, 24(5), 1997, pp. 824-829
HEPATITIS-B E-ANTIGEN (HBEAG) SEROCONVERSION IN 2 PATIENTS WITH EVIDENCE OF GENOTYPIC RESISTANCE FOLLOWING EXTENDED LAMIVUDINE TREATMENT
Authors: GARRETT L DIENSTAG JL GAUTHIER J CONDREAY L CROWTHER L GELB L SCHIFF ER BROWN NA
Citation: L. Garrett et al., HEPATITIS-B E-ANTIGEN (HBEAG) SEROCONVERSION IN 2 PATIENTS WITH EVIDENCE OF GENOTYPIC RESISTANCE FOLLOWING EXTENDED LAMIVUDINE TREATMENT, Hepatology, 26(4), 1997, pp. 1209-1209
SEXUAL AND PERINATAL TRANSMISSION OF HEPATITIS-C
Authors: DIENSTAG JL
Citation: Jl. Dienstag, SEXUAL AND PERINATAL TRANSMISSION OF HEPATITIS-C, Hepatology, 26(3), 1997, pp. 66-70
MANAGEMENT OF CHRONIC HEPATITIS-C - A CONSENSUS
Authors: DIENSTAG JL
Citation: Jl. Dienstag, MANAGEMENT OF CHRONIC HEPATITIS-C - A CONSENSUS, Gastroenterology, 113(2), 1997, pp. 375-375
NS5A MUTATIONS DO NOT PREDICT RESPONSE TO INTERFERON IN AMERICAN PATIENTS INFECTED WITH GENOTYPE-1 HEPATITIS-C-VIRUS
Authors: CHUNG RT MONTO A DIENSTAG JL KAPLAN LM
Citation: Rt. Chung et al., NS5A MUTATIONS DO NOT PREDICT RESPONSE TO INTERFERON IN AMERICAN PATIENTS INFECTED WITH GENOTYPE-1 HEPATITIS-C-VIRUS, Gastroenterology, 112(4), 1997, pp. 1244-1244
THE NATURAL-HISTORY OF CHRONIC HEPATITIS-C AND WHAT WE SHOULD DO ABOUT IT
Authors: DIENSTAG JL
Citation: Jl. Dienstag, THE NATURAL-HISTORY OF CHRONIC HEPATITIS-C AND WHAT WE SHOULD DO ABOUT IT, Gastroenterology, 112(2), 1997, pp. 651-655
EFFECT OF CYTOMEGALOVIRUS-INFECTION STATUS ON FIRST-YEAR MORTALITY-RATES AMONG ORTHOTOPIC LIVER-TRANSPLANT RECIPIENTS
Authors: FALAGAS ME SYNDMAN DR GRIFFITH J RUTHAZER R WERNER BG ROHRER R FREEMAN R FAIRCHILD R FAWAZ K HOFFMAN MA KAPLAN M GILL M RUBIN RH DIENSTAG JL DORAN M OROURKE E VACANTI J JENKINS R LEWIS WD HAMMER S MARTIN M GRADY GF LESZCZYNSKI J DOUGHERTY N KATZ A FAUSETT G PLATT R CHEESEMAN SH PASTERNACK M GORBACH SL
Citation: Me. Falagas et al., EFFECT OF CYTOMEGALOVIRUS-INFECTION STATUS ON FIRST-YEAR MORTALITY-RATES AMONG ORTHOTOPIC LIVER-TRANSPLANT RECIPIENTS, Annals of internal medicine, 126(4), 1997, pp. 275
EXPOSURE TO CYTOMEGALOVIRUS FROM THE DONATED ORGAN IS A RISK FACTOR FOR BACTEREMIA IN ORTHOTOPIC LIVER-TRANSPLANT RECIPIENTS
Authors: FALAGAS ME SNYDMAN DR GRIFFITH J WERNER BG ROHRER R FREEMAN R FAWAZ K HOFFMAN MA KAPLAN M GILL M RUBIN RH DIENSTAG JL DORAN M OROURKE E VACANTI J JENKINS R LEWIS WD HAMMER S MARTIN M FAIRCHILD R GRADY GF LESZCZYNSKI J DOUGHERTY N KATZ A FAUSETT G PLATT R CHEESEMAN SH PASTERNACK M GORBACH SL
Citation: Me. Falagas et al., EXPOSURE TO CYTOMEGALOVIRUS FROM THE DONATED ORGAN IS A RISK FACTOR FOR BACTEREMIA IN ORTHOTOPIC LIVER-TRANSPLANT RECIPIENTS, Clinical infectious diseases, 23(3), 1996, pp. 468-474
PRIMARY CYTOMEGALOVIRUS-INFECTION IN LIVER-TRANSPLANT RECIPIENTS - COMPARISON OF INFECTIONS TRANSMITTED VIA DONOR ORGANS AND VIA TRANSFUSIONS
Authors: FALAGAS ME SNYDMAN DR RUTHAZER R GRIFFITH J WERNER BG ROHRER R FREEMAN R FAWAZ K HOFFMAN MA KAPLAN M GILL M RUBIN RH DIENSTAG JL DORAN M OROURKE E VACANTI J JENKINS R LEWIS D HAMMER S MARTIN M FAIRCHILD R GRADY GF LESZCZYNSKI J DOUGHERTY N KATZ A FAUSETT G PLATT R CHEESEMAN SH PASTERNACK M GORBACH SL
Citation: Me. Falagas et al., PRIMARY CYTOMEGALOVIRUS-INFECTION IN LIVER-TRANSPLANT RECIPIENTS - COMPARISON OF INFECTIONS TRANSMITTED VIA DONOR ORGANS AND VIA TRANSFUSIONS, Clinical infectious diseases, 23(2), 1996, pp. 292-297
RESPONSE TO HIGHER DOSES OF INTERFERON ALFA-2B IN PATIENTS WITH CHRONIC HEPATITIS-C - A RANDOMIZED MULTICENTER TRIAL
Authors: LINDSAY KL DAVIS GL SCHIFF ER BODENHEIMER HC BALART LA DIENSTAG JL PERRILLO RP TAMBURRO CH GOFF JS EVERSON GT SILVA M KATKOV WN GOODMAN Z LAU JYN MAERTENS G GOGATE J SANGHVI B ALBRECHT J MILSTEIN S KNIFFEN J ROACH K BRODEUR C REGENSTEIN F TAYLOR B DEMELIA HC BODICKY C MILLER BL DANHOUR G BARILETTO S
Citation: Kl. Lindsay et al., RESPONSE TO HIGHER DOSES OF INTERFERON ALFA-2B IN PATIENTS WITH CHRONIC HEPATITIS-C - A RANDOMIZED MULTICENTER TRIAL, Hepatology, 24(5), 1996, pp. 1034-1040
EXTENDED LAMIVUDINE RETREATMENT FOR CHRONIC HEPATITIS-B
Authors: DIENSTAG JL SCHIFF ER MITCHELL M GITLIN N LISSOOS T CONDREAY L GARRETT L RUBIN M BROWN N
Citation: Jl. Dienstag et al., EXTENDED LAMIVUDINE RETREATMENT FOR CHRONIC HEPATITIS-B, Hepatology, 24(4), 1996, pp. 245-245
HEPATITIS-C VIRUS GENOTYPES AND VIREMIA, HEPATITIS-G VIRUS COINFECTION, AND HEPATOCELLULAR-CARCINOMA
Authors: REID AE KOZIEL MJ AIZA I JEFFERS L REDDY R SCHIFF E DIENSTAG JL LAU JYN LIANG TJ
Citation: Ae. Reid et al., HEPATITIS-C VIRUS GENOTYPES AND VIREMIA, HEPATITIS-G VIRUS COINFECTION, AND HEPATOCELLULAR-CARCINOMA, Hepatology, 24(4), 1996, pp. 879-879
CAN INTERFERON-ALFA TREATMENT PREVENT HEPATOCELLULAR-CARCINOMA IN PATIENTS WITH CHRONIC HEPATITIS-C INFECTION AND COMPENSATED CIRRHOSIS
Authors: HARPER SE DIENSTAG JL
Citation: Se. Harper et Jl. Dienstag, CAN INTERFERON-ALFA TREATMENT PREVENT HEPATOCELLULAR-CARCINOMA IN PATIENTS WITH CHRONIC HEPATITIS-C INFECTION AND COMPENSATED CIRRHOSIS, Hepatology, 23(4), 1996, pp. 930-933
INCIDENCE AND PREDICTORS OF CYTOMEGALOVIRUS PNEUMONIA IN ORTHOTOPIC LIVER-TRANSPLANT RECIPIENTS
Authors: FALAGAS ME SNYDMAN DR GEORGE MJ WERNER B RUTHAZER R GRIFFITH J ROHRER RH FREEMAN R GEORGE MG FAWAZ K HOFFMAN MA KAPLAN M GILL M RUBIN RH DIENSTAG JL DORNA M OROURKE E VACANTI J JENKINS R LEWIS WD HAMMER S MARTIN M FAIRCHILD R WERNER BG GRADY GF LESZCZYNSKI J DOUGHERTY N KATZ A FAUSETT G PLATT R CHEESEMAN SH PASTERNACK M GORBACH SL
Citation: Me. Falagas et al., INCIDENCE AND PREDICTORS OF CYTOMEGALOVIRUS PNEUMONIA IN ORTHOTOPIC LIVER-TRANSPLANT RECIPIENTS, Transplantation, 61(12), 1996, pp. 1716-1720
DISTRIBUTION OF HEPATITIS-C VIRUS GENOTYPES DETERMINED BY LINE PROBE ASSAY IN PATIENTS WITH CHRONIC HEPATITIS-C SEEN AT TERTIARY REFERRAL CENTERS IN THE UNITED-STATES
Authors: LAU JYN DAVIS GL PRESCOTT LE MAERTENS G LINDSAY KL QIAN KP MIZOKAMI M SIMMONDS P PERRILLO RP SCHIFF ER BODENHEIMER HC BALART LA REGENSTEIN F DIENSTAG JL KATKOV WN TAMBURRO CH GOFF JS EVERSON GT GOODMAN Z ALBRECHT J
Citation: Jyn. Lau et al., DISTRIBUTION OF HEPATITIS-C VIRUS GENOTYPES DETERMINED BY LINE PROBE ASSAY IN PATIENTS WITH CHRONIC HEPATITIS-C SEEN AT TERTIARY REFERRAL CENTERS IN THE UNITED-STATES, Annals of internal medicine, 124(10), 1996, pp. 868
PHARMACOKINETICS AND PHARMACODYNAMICS OF REMIFENTANIL IN VOLUNTEER SUBJECTS WITH SEVERE LIVER-DISEASE
Authors: DERSHWITZ M HOKE JF ROSOW CE MICHALOWSKI P CONNORS PM MUIR KT DIENSTAG JL
Citation: M. Dershwitz et al., PHARMACOKINETICS AND PHARMACODYNAMICS OF REMIFENTANIL IN VOLUNTEER SUBJECTS WITH SEVERE LIVER-DISEASE, Anesthesiology, 84(4), 1996, pp. 812-820
HEPATITIS VACCINES
Authors: KATKOV WN DIENSTAG JL
Citation: Wn. Katkov et Jl. Dienstag, HEPATITIS VACCINES, Gastroenterology clinics of North America, 24(1), 1995, pp. 147-159
EXTRAHEPATIC MANIFESTATIONS OF HEPATITIS-C AND THE ASSOCIATION WITH ALCOHOLIC LIVER-DISEASE
Authors: KOFF RS DIENSTAG JL
Citation: Rs. Koff et Jl. Dienstag, EXTRAHEPATIC MANIFESTATIONS OF HEPATITIS-C AND THE ASSOCIATION WITH ALCOHOLIC LIVER-DISEASE, Seminars in liver disease, 15(1), 1995, pp. 101-109
REDUCTION IN HEPATITIS-B VIRUS QUASI-SPECIES DURING LAMIVUDINE TREATMENT IS ASSOCIATED WITH ENHANCED VIRUS-REPLICATION AND HEPATOCYTOLYSIS
Authors: NAOUMOV NV PERRILLO RP CHOKSHI S DIENSTAG JL VICARY C BROWN N WILLIAMS R
Citation: Nv. Naoumov et al., REDUCTION IN HEPATITIS-B VIRUS QUASI-SPECIES DURING LAMIVUDINE TREATMENT IS ASSOCIATED WITH ENHANCED VIRUS-REPLICATION AND HEPATOCYTOLYSIS, Hepatology, 22(4), 1995, pp. 885-885
AUTOLOGOUS LYMPHOCYTE THERAPY (ALT) FOR CHRONIC HEPATITIS-B - A PRELIMINARY-STUDY IN CHIMPANZEES
Authors: DIBISCEGLIE AM BABBITT BP CAPLAN B BHAN AK RALL CJN DIENSTAG JL
Citation: Am. Dibisceglie et al., AUTOLOGOUS LYMPHOCYTE THERAPY (ALT) FOR CHRONIC HEPATITIS-B - A PRELIMINARY-STUDY IN CHIMPANZEES, Hepatology, 22(4), 1995, pp. 892-892
A PRELIMINARY TRIAL OF LAMIVUDINE FOR CHRONIC HEPATITIS-B INFECTION
Authors: DIENSTAG JL PERRILLO RP SCHIFF ER BARTHOLOMEW M VICARY C RUBIN M
Citation: Jl. Dienstag et al., A PRELIMINARY TRIAL OF LAMIVUDINE FOR CHRONIC HEPATITIS-B INFECTION, The New England journal of medicine, 333(25), 1995, pp. 1657-1661
DOUBLE-BLIND, RANDOMIZED, 3-MONTH, DOSE-RANGING TRIAL OF LAMIVUDINE FOR CHRONIC HEPATITIS-B
Authors: DIENSTAG JL PERRILLO RP SCHIFF ER BARTHOLOMEW M VICARY C RUBIN M
Citation: Jl. Dienstag et al., DOUBLE-BLIND, RANDOMIZED, 3-MONTH, DOSE-RANGING TRIAL OF LAMIVUDINE FOR CHRONIC HEPATITIS-B, Hepatology, 20(4), 1994, pp. 10000199-10000199
Risultati: 1-25 | 26-31